Business Insider's July 30 virtual event features executives talking about procurement innovation strategies. The panel features experts from Bristol-Myers Squibb and Amazon Business.

Antitumor activity observed in the ongoing open-label phase 2 study, LITESPARK-004 (NCT03401788), led to the approval of belzutifan for the treatment of patients with VHL disease who require therapy ...